Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 5,678,000 | 3,586,000 | 4,792,000 | 3,420,000 | 3,351,000 |
| Income taxes - deferred | -2,439,000 | -802,000 | -970,000 | -578,000 | -356,000 |
| Accounts receivable | -1,202,000 | -28,000 | -397,000 | -777,000 | 185,000 |
| Accounts payable and accrued liabilities | 398,000 | 789,000 | 402,000 | 452,000 | 451,000 |
| Other Working Capital | 1,795,000 | -615,000 | 764,000 | -707,000 | 1,409,000 |
| Other Operating Activity | 6,520,000 | 6,151,000 | 5,667,000 | 8,716,000 | 5,482,000 |
| Operating Cash Flow | $10,750,000 | $9,081,000 | $10,258,000 | $10,526,000 | $10,522,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,691,000 | -1,734,000 | -2,009,000 | -713,000 | -1,325,000 |
| Net Acquisitions | -10,078,000 | -2,524,000 | -3,828,000 | -858,000 | -5,594,000 |
| Purchase Of Investment | N/A | N/A | -134,000 | -488,000 | -311,000 |
| Other Investing Activity | 10,322,000 | -149,000 | -229,000 | -16,000 | -68,000 |
| Investing Cash Flow | $-2,447,000 | $-4,407,000 | $-6,200,000 | $-2,075,000 | $-7,298,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,100,000 | 59,000 | 765,000 | 215,000 | -414,000 |
| Debt Issued | 5,559,000 | 0 | 48,000 | 1,549,000 | 0 |
| Debt Repayment | -2,955,000 | -953,000 | -3,949,000 | -3,009,000 | -2,390,000 |
| Common Stock Issued | 177,000 | 187,000 | 195,000 | 188,000 | 186,000 |
| Common Stock Repurchased | -5,030,000 | -302,000 | -593,000 | -497,000 | -382,000 |
| Dividend Paid | -4,772,000 | -4,704,000 | -4,454,000 | -4,168,000 | -4,008,000 |
| Other Financing Activity | -86,000 | -50,000 | -64,000 | -99,000 | -48,000 |
| Financing Cash Flow | $-8,207,000 | $-5,763,000 | $-8,052,000 | $-5,821,000 | $-7,056,000 |
| Exchange Rate Effect | -47,000 | -13,000 | -32,000 | 8,000 | 15,000 |
| Beginning Cash Position | 7,441,000 | 8,710,000 | 12,736,000 | 10,098,000 | 13,915,000 |
| End Cash Position | 7,657,000 | 7,441,000 | 8,710,000 | 12,736,000 | 10,098,000 |
| Net Cash Flow | $263,000 | $-1,256,000 | $-3,994,000 | $2,630,000 | $-3,832,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,750,000 | 9,081,000 | 10,258,000 | 10,526,000 | 10,522,000 |
| Capital Expenditure | -3,538,000 | -3,195,000 | -3,024,000 | -2,201,000 | -2,043,000 |
| Free Cash Flow | 7,212,000 | 5,886,000 | 7,234,000 | 8,325,000 | 8,479,000 |